MarketPR
HEALTHFDA forms board to guide drug exclusivity rulingsOct 19WORLDTrump endorses Netanyahu 9 days before Israel electionOct 18$NEARNFL monitors France unrest before Saints-Steelers game near ParisOct 18EARNINGSHSBC Sees Q3 Earnings and AI Demand Supporting Global EquitiesOct 18EARNINGSWilliam Shatner releases heavy metal album with The *uckers at 95Oct 18WORLDFive top eight teams lose in college football, BYU upsets Notre DameOct 18MARKETSOutstanding margin debt hits $1.5 trillion, a record highOct 18WORLDEuropean Parliament passes resolution targeting Muslim Brotherhood influenceOct 18EARNINGSS&P 500 companies issue record upbeat earnings guidanceOct 18WORLDFatalities reported at Canadian Forces Base Wainwright fireOct 18HEALTHFDA forms board to guide drug exclusivity rulingsOct 19WORLDTrump endorses Netanyahu 9 days before Israel electionOct 18$NEARNFL monitors France unrest before Saints-Steelers game near ParisOct 18EARNINGSHSBC Sees Q3 Earnings and AI Demand Supporting Global EquitiesOct 18EARNINGSWilliam Shatner releases heavy metal album with The *uckers at 95Oct 18WORLDFive top eight teams lose in college football, BYU upsets Notre DameOct 18MARKETSOutstanding margin debt hits $1.5 trillion, a record highOct 18WORLDEuropean Parliament passes resolution targeting Muslim Brotherhood influenceOct 18EARNINGSS&P 500 companies issue record upbeat earnings guidanceOct 18WORLDFatalities reported at Canadian Forces Base Wainwright fireOct 18
NewsMacro

Trump puts a number on pharma concentration: 26 companies, 90% of the market

Twenty-six companies account for 90% of the United States pharmaceutical market, according to Donald Trump. The figure places domestic drug supply capacity within a narrow set of producers and raises direct questions about where throughput and order-book concentration actually sit across the sector.

By Renata OstrowskiNewsroomAugust 31, 20262 min read
Share

Key takeaways

  • Donald Trump claimed that 26 companies account for 90% of the United States pharmaceutical market.
  • Trump provided no breakdown by company name, product segment, or revenue share to support the figure.
  • The claim implies a long tail of smaller producers holds the remaining 10% of the market, though Trump did not characterize that segment.
  • There is no named methodology or independent verification, so the figure stands only as Trump's stated description.
  • Whether the claim becomes part of a formal policy instrument or official filing is the next confirmable step.

Twenty-six companies account for 90% of the United States pharmaceutical market, according to Donald Trump. The figure places domestic drug supply capacity within a narrow set of producers and raises direct questions about where throughput and order-book concentration actually sit across the sector.

Trump offered no breakdown by company name, product segment, or revenue share alongside the claim. A market where 26 entities carry nine-tenths of output implies a long tail of smaller producers holds the remaining share, though Trump did not characterize that segment or its role in overall capacity. Without a named methodology or independent verification, the figure stands as Trump's stated description of how the sector is structured.

Whether the claim moves into a formal policy instrument or official filing is the next confirmable step. A presidential characterization carries a different weight than a regulatory determination, and until one of those materializes, the 26-company figure remains attributed to Trump alone.

Related reading

About this story

Filed by the newsroom of MarketPR on August 31, 2026. Source: MarketPR newsroom. Indicative figures are not investment advice.

←Back to the news index

More from the Newsroom

All stories →
01Macro

Anthropic taps nonprofits METR and SecureBio to help assess risks and safety practices

Anthropic announced Thursday that it is collaborating with the nonprofits METR and SecureBio to embed independent evaluators within its operations. The company is also in discussions with additional organizations, including Hugging Face…

Renata Ostrowski2 min read
02Macro

Chris Janson credits dry Colorado weather for delayed elk hunt success

Chris Janson returned from a successful elk hunt in Colorado, crediting unusually dry weather for a week of missed opportunities that ended with a bull harvest in the low country. The country music star has made annual trips to the state…

Renata Ostrowski2 min read
03Macro

Memory stocks fall on China competition and 2029 oversupply fears

Memory chip equities have declined sharply this week as investors weigh the competitive threat from China against speculation about a future market glut. SK Hynix shares fell 26%, Samsung dropped 22% and Micron declined approximately 11%…

Renata Ostrowski2 min read

Frequently asked

How many companies did Trump say control the U.S. pharmaceutical market?

Trump said 26 companies account for 90% of the United States pharmaceutical market.

Did Trump provide evidence or a methodology for the figure?

No, Trump offered no breakdown by company name, product segment, or revenue share, and gave no named methodology or independent verification.

Is the 26-company figure an official government determination?

No, it remains a presidential characterization attributed to Trump alone unless it moves into a formal policy instrument or official filing.

What happens to the remaining share of the market not held by the 26 companies?

The claim implies a long tail of smaller producers holds the remaining share, but Trump did not characterize that segment or its role in overall capacity.